United Therapeutics CFO sells 10K shares after option
UNITED THERAPEUTICS Corp CFO and Treasurer James Edgemond exercised stock options for 10,000 shares of Common Stock at a price of $117.76 per share and, on the same date, sold 10,000 shares of Common Stock in a series of open-market transactions.
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp CFO and Treasurer James Edgemond exercised stock options for 10,000 shares of Common Stock at a price of $117.76 per share and, on the same date, sold 10,000 shares of Common Stock in a series of open-market transactions.
The reported sales occurred at weighted average prices ranging from approximately $561.48 to $571.48 per share, pursuant to a pre-arranged Rule 10b5-1 trading plan entered into on October 31, 2025. Following these transactions, Edgemond directly holds 18,876 shares of Common Stock and 50,000 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,000 shares ($4.48M approx. pre-tax spread)
Exercise and Sale
12 txns
Insider
EDGEMOND JAMES
Role
CFO AND TREASURER
Sold
10,000 shs ($5.66M)
Approx. gross sale proceeds
$5.66M
Approx. exercise cost
$1.18M
Approx. pre-tax spread
$4.48M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $117.76 | $1.18M |
| Sale | Common Stock | 320 | $561.4823 | $180K |
| Sale | Common Stock | 1,961 | $562.7676 | $1.10M |
| Sale | Common Stock | 1,675 | $563.8743 | $944K |
| Sale | Common Stock | 1,208 | $564.8205 | $682K |
| Sale | Common Stock | 893 | $565.9956 | $505K |
| Sale | Common Stock | 934 | $566.8663 | $529K |
| Sale | Common Stock | 1,605 | $567.9143 | $912K |
| Sale | Common Stock | 844 | $568.9008 | $480K |
| Sale | Common Stock | 332 | $570.4955 | $189K |
| Sale | Common Stock | 228 | $571.4811 | $130K |
Holdings After Transaction:
Stock Option — 50,000 contracts (Direct);
Common Stock — 18,876 shares (Direct)
Footnotes (11)
- F1. This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
- F10. This transaction was executed in multiple trades at prices ranging from $570.01 to $570.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. This transaction was executed in multiple trades at prices ranging from $571.06 to $571.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2. This transaction was executed in multiple trades at prices ranging from $561.09 to $562.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $562.38 to $563.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $563.39 to $564.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $564.40 to $565.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $565.42 to $566.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $566.46 to $567.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $567.46 to $568.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $568.55 to $569.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 10,000 shares
Option exercise size: 10,000 shares
Option exercise price: $117.76 per share
+4 more
7 metrics
Shares sold
10,000 shares
Total Common Stock sold across 10 open-market transactions
Option exercise size
10,000 shares
Common Stock acquired via stock option exercise
Option exercise price
$117.76 per share
Exercise price for 10,000 stock options
Sale price (example)
$571.4811 per share
Weighted average price for a 228-share sale lot
Shares held after
18,876 shares
Common Stock directly owned following transactions
Options remaining
50,000 options
Stock options outstanding after the reported exercise
Net share activity
-10,000 shares
Net buy/sell direction from transaction summary
Key Terms
Rule 10b5-1 trading plan, stock options, weighted average price, open-market sale, +1 more
5 terms
Rule 10b5-1 trading plan financial
"exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
stock options financial
"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
weighted average price financial
"The price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action": "open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did United Therapeutics (UTHR) CFO James Edgemond do in this Form 4 filing?
CFO James Edgemond exercised stock options for 10,000 United Therapeutics shares and sold 10,000 shares in open-market transactions. These actions were reported as part of a routine Form 4 insider trading disclosure with detailed share and price information.
Did the United Therapeutics (UTHR) CFO exercise stock options in this transaction?
Yes, the CFO exercised stock options covering 10,000 United Therapeutics Common Stock shares at an exercise price of $117.76 per share. This option exercise was followed by open-market sales of an equal number of underlying common shares on the same date.
Were the United Therapeutics (UTHR) CFO’s trades made under a Rule 10b5-1 plan?
Yes, the filing states that the stock option exercise and subsequent sale of shares were made pursuant to a Rule 10b5-1 trading plan. That plan was entered into by the reporting person on October 31, 2025, indicating the transactions were pre-arranged rather than ad hoc.
What is the net effect of these insider transactions on the CFO’s United Therapeutics (UTHR) position?
The CFO exercised 10,000 options and sold 10,000 common shares, with Form 4 summary data showing net sell activity of 10,000 shares. He still directly holds 18,876 common shares and 50,000 stock options, maintaining a significant ongoing equity interest.
AI-generated analysis. How Rhea-AI works. Not financial advice.
